PSNL Personalis Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Personalis Corp (PSNL) - korporativ logo

Personalis, Inc. (PSNL) uchun ushbu narxlar dinamikasi grafigi farmatsevtika sektori uchun yuqori texnologiyali genom tahlili va DNK sekvensirlash orqali daromad keltiradigan biznesning baholanishini aks ettiradi. Rahbariyat o'z metodlarining isbotlangan samaradorligidan foydalangan holda, sanoat yetakchilari bilan ittifoqlar orqali diagnostika platformasini faol ravishda kengaytirmoqda. Joriy ko'rsatkich 7.30 darajasida bo'lib, o'sish MRD testlarining joriy etilishi va innovatsion skrininglar uchun sug'urta qamrovining kengayishi hisobiga ta'minlanmoqda.

Personalis, Inc. (PSNL) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

PSNL (Personalis Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Personalis, Inc.|PSNL - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Personalis Corp|PSNL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Personalis|PSNL - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati personalis.com|PSNL - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Personalis, Inc.|PSNL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Personalis Corp|PSNL - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Personalis Corp
Fundamental baholash:PSNL (Personalis, Inc.)
Personalis Inc tayyor mahsulotlari

Konservativ kapital yuqori texnologik sektorlarga investitsiya kiritishda "qiymat tuzog'i" xavfini bartaraf etish uchun sof aktivlarning shaffof baholashini talab qiladi. Ushbu ko'rsatkich Personalis, Inc. (PSNL) bozor qiymatini uning balans qiymati bilan solishtirib, real kapitalga nisbatan premium yoki diskontni namoyish etadi, bu esa mualliflik genom sekvenslash tizimlari ishlab chiquvchisi uchun juda muhimdir. Tarixiy bozor-balans koeffitsiyentini tahlil qilish universal laboratoriyalar bilan bo'lgan shiddatli raqobat sharoitida biznesning barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati erasca.com ERAS|DCTH: Bozor kapitallashuvining balans qiymatiga nisbati|YMAB - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AURA|CADL (Candel Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ARAY - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|TARA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CVM|OSTX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Radiopharm Theranostics Ltd (RADX)|ARTV: Bozor kapitallashuvining balans qiymatiga nisbati|Adlai Nortye Ltd - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Veru Pharma (VERU)|TPST: Balans qiymatiga nisbatan bozor qiymati|xiliotx.com - Bozor qiymatining balans qiymatiga nisbati|RENB (Renovaro) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati MURA (Mural Oncology PLC)|Bozor qiymatining balans qiymatiga koeffitsiyenti KAPA|Bozor qiymatining balans qiymatiga nisbati OnKure Therapeutics Inc OKUR|Kapitallashuvning balans qiymatiga nisbati w2.cytomed.sg (GDTC)|Bozor kapitallashuvining balans qiymatiga nisbati CRIS (Curis)|Apollomics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|THAR - Bozor qiymatining balans qiymatiga nisbati|ADVB - Bozor qiymatining balans qiymatiga nisbati|Genprex, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|CLDI (Calidi Biotherapeutics, Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi|SBFM: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Xenetic Bio (XBIO)|Salarius Pharmaceuticals, Inc. (SLRX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Purple Biotech Ltd (PPBT)|Bozor kapitallashuvining balans qiymatiga nisbati AONC|BeiGene Ltd - Balans qiymatiga nisbatan bozor kapitallashuvi|Checkpoint Therapeutics (CKPT) - Bozor qiymatining balans qiymatiga nisbati|ELEV - Kapitallashuvning balans qiymatiga nisbati|ICAD (icadmed.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ikena Oncology|NTBL: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi VIRX|MOR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi NAYA (nayabiosciences.com)|Bozor qiymatining balans qiymatiga nisbati AAPGV